Subventions financées

Alzheimer’s Disease (AD) is characterized by memory decline and neuronal pathology, including amyloid β (Aβ)plaques and oxidative stress.

Nearly half the people affected with Alzheimer’s disease will at some point show reduced motivation to perform their daily activities or participate in activities they previously enjoyed.

Stephanie Borlase is investigating ways to improve immunotherapies to treat people whose lung cancer has spread to the brain, improving outcomes.

In this study, we. aim to do two things: 1) monitor the distribution of a-Syn in Parkinson’s disease (PD) context to understand the factors that can cause a-Syn to build-up in certain cells of the brain, called microglia.

Alzheimer’s disease (AD) is the most common form of dementia and 7th leading cause of death in North-America.

Our research project will investigate the relationship between physical activity and brain vascular health in women.

Individuals with an incurable condition marked by decline and intolerable suffering and where death is reasonably foreseeable, as with dementia, now have access to medical assistance in dying (MAID).

Age-related dementias are reaching epidemic levels, affecting over 600,000 Canadians.

Alzheimer’s disease is a common form of memory loss and confusion affecting older adults. Despite many years of study, we still don’t have a cure for this disease.